Literature DB >> 19881548

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

R J DeBerardinis1, T Cheng.   

Abstract

Several decades of research have sought to characterize tumor cell metabolism in the hope that tumor-specific activities can be exploited to treat cancer. Having originated from Warburg's seminal observation of aerobic glycolysis in tumor cells, most of this attention has focused on glucose metabolism. However, since the 1950s cancer biologists have also recognized the importance of glutamine (Q) as a tumor nutrient. Glutamine contributes to essentially every core metabolic task of proliferating tumor cells: it participates in bioenergetics, supports cell defenses against oxidative stress and complements glucose metabolism in the production of macromolecules. The interest in glutamine metabolism has been heightened further by the recent findings that c-myc controls glutamine uptake and degradation, and that glutamine itself exerts influence over a number of signaling pathways that contribute to tumor growth. These observations are stimulating a renewed effort to understand the regulation of glutamine metabolism in tumors and to develop strategies to target glutamine metabolism in cancer. In this study we review the protean roles of glutamine in cancer, both in the direct support of tumor growth and in mediating some of the complex effects on whole-body metabolism that are characteristic of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19881548      PMCID: PMC2809806          DOI: 10.1038/onc.2009.358

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  83 in total

1.  Aerobic glycolysis during lymphocyte proliferation.

Authors:  T Wang; C Marquardt; J Foker
Journal:  Nature       Date:  1976-06-24       Impact factor: 49.962

2.  Glutaminase activities and growth rates of rat hepatomas.

Authors:  M Linder-Horowitz; W E Knox; H P Morris
Journal:  Cancer Res       Date:  1969-06       Impact factor: 12.701

3.  Intracellular free amino acid concentration in human muscle tissue.

Authors:  J Bergström; P Fürst; L O Norée; E Vinnars
Journal:  J Appl Physiol       Date:  1974-06       Impact factor: 3.531

4.  The proportionality of glutaminase content to growth rate and morphology of rat neoplasms.

Authors:  W E Knox; M L Horowitz; G H Friedell
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

Review 5.  Mitochondrial metabolism of glutamine and glutamate and its physiological significance.

Authors:  Z Kovacevic; J D McGivan
Journal:  Physiol Rev       Date:  1983-04       Impact factor: 37.312

6.  Amino acid, glucose, and lactic acid utilization in vivo by rat tumors.

Authors:  L A Sauer; J W Stayman; R T Dauchy
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

7.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

8.  Glucose metabolism in cachectic patients with colorectal cancer.

Authors:  C P Holroyde; C L Skutches; G Boden; G A Reichard
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism.

Authors:  K Brand
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

10.  Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats.

Authors:  L A Sauer; R T Dauchy
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

View more
  552 in total

1.  Breathless cancer cells get fat on glutamine.

Authors:  Dimitrios Anastasiou; Lewis C Cantley
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

Review 2.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 3.  Cellular metabolism and disease: what do metabolic outliers teach us?

Authors:  Ralph J DeBerardinis; Craig B Thompson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

4.  p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.

Authors:  Hilaire C Lam; Christian V Baglini; Alicia Llorente Lope; Andrey A Parkhitko; Heng-Jia Liu; Nicola Alesi; Izabela A Malinowska; Darius Ebrahimi-Fakhari; Afshin Saffari; Jane J Yu; Ana Pereira; Damir Khabibullin; Barbara Ogorek; Julie Nijmeh; Taylor Kavanagh; Adam Handen; Stephen Y Chan; John M Asara; William M Oldham; Maria T Diaz-Meco; Jorge Moscat; Mustafa Sahin; Carmen Priolo; Elizabeth P Henske
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

5.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.

Authors:  Yun-Yong Park; Bo Hwa Sohn; Randy L Johnson; Myoung-Hee Kang; Sang Bae Kim; Jae-Jun Shim; Lingegowda S Mangala; Ji Hoon Kim; Jeong Eun Yoo; Cristian Rodriguez-Aguayo; Sunila Pradeep; Jun Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Rajesha Rupaimoole; Gabriel Lopez-Berestein; Woojin Jeong; Inn Sun Park; Young Nyun Park; Anil K Sood; Gordon B Mills; Ju-Seog Lee
Journal:  Hepatology       Date:  2015-11-26       Impact factor: 17.425

Review 6.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 7.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

Review 8.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

Review 9.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

10.  Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Authors:  Darin Salloum; Suman Mukhopadhyay; Kaity Tung; Aleksandra Polonetskaya; David A Foster
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.